NM_032977.4:c.259C>T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_032977.4(CASP10):​c.259C>T​(p.Arg87Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,613,090 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R87G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00016 ( 1 hom. )

Consequence

CASP10
NM_032977.4 missense

Scores

1
5
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 1.37

Publications

3 publications found
Variant links:
Genes affected
CASP10 (HGNC:1500): (caspase 10) This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 3 and 7, and the protein itself is processed by caspase 8. Mutations in this gene are associated with type IIA autoimmune lymphoproliferative syndrome, non-Hodgkin lymphoma and gastric cancer. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CASP10 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2A
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autoimmune lymphoproliferative syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.19718623).
BS2
High AC in GnomAd4 at 16 Unknown,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032977.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP10
NM_032977.4
MANE Select
c.259C>Tp.Arg87Trp
missense
Exon 2 of 10NP_116759.2
CASP10
NM_032974.5
c.259C>Tp.Arg87Trp
missense
Exon 2 of 10NP_116756.2
CASP10
NM_001230.5
c.259C>Tp.Arg87Trp
missense
Exon 2 of 8NP_001221.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP10
ENST00000286186.11
TSL:1 MANE Select
c.259C>Tp.Arg87Trp
missense
Exon 2 of 10ENSP00000286186.6
CASP10
ENST00000448480.1
TSL:1
c.259C>Tp.Arg87Trp
missense
Exon 2 of 8ENSP00000396835.1
CASP10
ENST00000313728.12
TSL:1
c.259C>Tp.Arg87Trp
missense
Exon 2 of 8ENSP00000314599.7

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152122
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000188
AC:
47
AN:
249814
AF XY:
0.000237
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000637
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000116
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.000162
AC:
237
AN:
1460968
Hom.:
1
Cov.:
32
AF XY:
0.000164
AC XY:
119
AN XY:
726792
show subpopulations
African (AFR)
AF:
0.0000897
AC:
3
AN:
33452
American (AMR)
AF:
0.000559
AC:
25
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86220
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53384
Middle Eastern (MID)
AF:
0.000985
AC:
5
AN:
5078
European-Non Finnish (NFE)
AF:
0.000149
AC:
166
AN:
1111962
Other (OTH)
AF:
0.000332
AC:
20
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152122
Hom.:
0
Cov.:
32
AF XY:
0.0000942
AC XY:
7
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41424
American (AMR)
AF:
0.000197
AC:
3
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000119
Hom.:
0
Bravo
AF:
0.000140
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.000148
AC:
18
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Autoimmune lymphoproliferative syndrome type 2A (2)
-
1
-
Gastric cancer;C1858968:Autoimmune lymphoproliferative syndrome type 2A;C4721532:Lymphoma, non-Hodgkin, familial (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.69
D
Eigen
Benign
-0.99
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.12
N
LIST_S2
Uncertain
0.93
D
M_CAP
Benign
0.068
D
MetaRNN
Benign
0.20
T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
1.8
L
PhyloP100
1.4
PrimateAI
Benign
0.30
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Benign
0.24
Sift
Uncertain
0.0060
D
Sift4G
Uncertain
0.0090
D
Polyphen
0.99
D
Vest4
0.31
MutPred
0.72
Gain of helix (P = 0.0496)
MVP
0.81
MPC
0.36
ClinPred
0.10
T
GERP RS
-1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.18
gMVP
0.28
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs551818122; hg19: chr2-202050759; COSMIC: COSV53779215; COSMIC: COSV53779215; API